Analysts await Vical Incorporated (NASDAQ:VICL) to report earnings on Mar, 14 for the fiscal quarter ending Dec 2015.

They expect $-0.02 EPS, up 150% or $0.03 from last year’s $-0.05 per share.

At the moment 2 analysts are watching Vical Incorporated (NASDAQ:VICL), 0 rate it “Buy”, 1 “Outperform”, 1 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Mar-16, 1 analyst has a mean sales target of 5.12 million. For the quarter ending Jun-16, 1 analyst has a mean sales target of 5.17 million whilst for the year ending Dec-16, 3 analysts have a mean target of 12.76 million.

In terms of earnings per share, 1 analyst has a -0.03 EPS mean target for the quarter ending Mar-16, for the quarter ending Jun-16, 1 analyst has a -0.03 EPS mean target and for the quarter ending Jun-16 there are 3 estimates of -0.18 EPS.

Total shares held by institutions as of the most recent company filings are with a reported bought and sold. These holdings make up of the company’s outstanding shares.

The stock decreased 2.569% or $0.011 during the last trading session, hitting $200000.000. Vical Incorporated (NASDAQ:VICL) has risen 100% over the past 6 months and is uptrending.